COMMUNIQUÉS West-GlobeNewswire

Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic Tests in the Middle East and Africa
16/07/2019
Inivata Signs Distribution Agreement with IPS Genomix for InVision ® Genomic Tests in the Middle East and Africa Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 -- Inivata , a leader in [...]
YSS Corp. Announces Receipt of Eleventh Retail Cannabis Store License
16/07/2019
CALGARY, Alberta, July 16, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce the receipt of an additional cannabis retail license from the Alberta Gaming, [...]
Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year
16/07/2019
SOUTH SAN FRANCISCO, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Kane Biotech Announces New Agreement with FreeMind Group
16/07/2019
WINNIPEG, Manitoba, July 16, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019
16/07/2019
Company Announcement Net sales of DARZALEX ® in the second quarter of 2019 totaled USD 774 million Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; July 16, 2019 – Genmab [...]
Exactus Inc. Announces Appointment of New Chief Financial Officer
16/07/2019
Seasoned, Strategic Finance Executive Kenneth E. Puzder Joins Exactus Senior Management Team DELRAY BEACH, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) – (the “Company”), a healthcare company [...]
CorVel Announces Quarterly Earnings Release Webcast
16/07/2019
IRVINE, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien, Chief Financial Officer Date: Tuesday July 30, [...]
Immuron North American revenue surges by 52% in FY19
16/07/2019
Key Highlights: Immuron FY19 revenue surged by 52% in North America, reaching $1.16M. In the USA, FY19 Travelan® sales exceeded the $1M AUD milestone for the first time and grew by +32% to $1.02M AUD. In May 2019, USA [...]
ROSINBOMB Announces Their Patent Pending Flow Channel Technology™ Enabling Mass Production of Solventless Oils and Extracts
16/07/2019
Revolutionary Technology Poised to Disrupt the Multibillion Dollar Extract Market RENO, Nev., July 16, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), manufacturer of the highly acclaimed ROSINBOMB™ [...]
Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio
16/07/2019
MANCHESTER, United Kingdom, July 16, 2019 (GLOBE NEWSWIRE) -- Epistem Limited, the UK based pre-clinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion [...]
Transactions in relation to share buyback program
16/07/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
CellaVision ABs strongest quarter ever with continued growth
16/07/2019
The information was submitted for publication at 08.20 CET on July 16, 2019 April 1–June 31, 2019 Net sales increased by 22% to SEK 112.4 million (91.9). Net sales increased organically by 18% (15). Operating profit [...]
Nicox Announces Completion of Enrollment in NCX 470 Phase 2 Clinical Study with Top-Line Results on Track for Early 4Q 2019
16/07/2019
Press Release Nicox Announces Completion of Enrollment in NCX 470 Phase 2 Clinical Study with Top-Line Results on Track for Early 4Q 2019 July 16, 2019 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ( [...]
Nicox : Recrutement terminé dans l’étude clinique de phase 2 pour le NCX 470 – Premiers résultats attendus au début du quatrième trimestre 2019
16/07/2019
Communiqué de presse Nicox : Recrutement terminé dans l’étude clinique de phase 2 pour le NCX 470 – Premiers résultats attendus au début du quatrième trimestre 2019 16 juillet 2019 – diffusion à 07h30 Sophia Antipolis, [...]
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
16/07/2019
FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease, shortening FDA review to six months from standard ten months Vaso- [...]
Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release
15/07/2019
Innovate undertakes succession planning for a chief executive officer Finance team strengthened and well positioned for future growth Second quarter earnings release expected August 8, 2019 RALEIGH, N.C., July 15, 2019 [...]
electroCore Files Registration Statement on Form S-3
15/07/2019
BASKING RIDGE, N.J., July 15, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has filed a "universal shelf" registration statement on [...]
Eyenovia, Inc. Announces Closing of Public Offering
15/07/2019
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Conformis Establishes Alliance to Focus on ASC Joint Replacement
15/07/2019
BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]

Pages